56 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Mudaranthakam DP, Harlan-Williams LM, Jensen RA, Kuo H, Garimella V, Chen RC, Mayo MS, Krebill H. OPTIK: a database for understanding catchment areas to guide mobilization of cancer center assets. Database : the Journal of Biological Databases and Curation. 2020. PMID 32719846 DOI: 10.1093/Database/Baaa054  0.36
2020 Sayed A, Choudhury S, Subramaniam D, Gunewardena S, Ponnurangam S, Dandawate P, Umar S, Jensen R, Thomas S, Anant S. RNA Binding Protein RBM3 Modulates Novel LncRNAs to Increase Tumor Progression in Colon Cancer Cells The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.07588  0.52
2019 Dandawate P, Ghosh C, Palaniyandi K, Paul S, Rawal S, Pradhan R, Ali Sayed AA, Choudhury S, Standing D, Subramaniam D, Padhye S, Gunewardena S, Thomas SM, Neil MO, Tawfik O, ... ... Jensen RA, et al. The Histone Demethylase KDM3A, Increased in Human Pancreatic Tumors, Regulates Expression of DCLK1 in and Promotes Tumorigenesis in Mice. Gastroenterology. PMID 31442435 DOI: 10.1053/J.Gastro.2019.08.018  0.52
2019 New J, Subramaniam D, Ramalingam S, Enders J, Sayed AAA, Ponnurangam S, Standing D, Ramamoorthy P, O'Neil M, Dixon DA, Saha S, Umar S, Gunewardena S, Jensen RA, Thomas SM, et al. Pleotropic role of RNA binding protein CELF2 in autophagy induction. Molecular Carcinogenesis. PMID 31020708 DOI: 10.1002/Mc.23023  0.52
2019 Li D, Harlan-Williams LM, Kumaraswamy E, Jensen RA. BRCA1-No Matter How You Splice It. Cancer Research. PMID 30992324 DOI: 10.1158/0008-5472.Can-18-3190  0.56
2019 Ramamoorthy P, Thomas SM, Kaushik G, Subramaniam D, Chastain KM, Dhar A, Tawfik O, Kasi A, Sun W, Ramalingam S, Gunewardena S, Umar S, Mammen JMV, Padhye SB, Weir SJ, ... Jensen RA, et al. Metastatic Tumor-In-A-Dish, A Novel Multi-Cellular Organoid to Study Lung Colonization and Predict Therapeutic Response. Cancer Research. PMID 30674533 DOI: 10.1158/0008-5472.Can-18-2602  0.52
2019 Ghosh C, Palaniyandi K, Paul S, Dandawate P, Rawal S, Subramaniam D, Padhye S, Gunewardena S, Thomas S, O'Neil M, Jensen R, Welch D, Milisky S, Weir S, Iwakuma T, et al. Abstract 4398: KDM3A and DCLK1 interactions promote stemness and tumorigenesis in PDAC Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-4398  0.52
2018 Sayed AAA, Subramaniam D, Gunewardena S, Ponnurangam S, Choudhury S, Enders J, Jensen RA, Thomas SM, Umar S, Anant S. 520 - RBM3 Increases Tumor Progression by Increasing Stemness and Metastasis in Colon Cancer Gastroenterology. 154. DOI: 10.1016/S0016-5085(18)30819-9  0.52
2016 Mackay CB, Gurley-Calvez T, Erickson KD, Jensen RA. Clinical trial insurance coverage for cancer patients under the Affordable Care Act Contemporary Clinical Trials Communications. 2: 69-74. DOI: 10.1016/j.conctc.2015.12.002  0.52
2015 Kumaraswamy E, Wendt KL, Augustine LA, Stecklein SR, Sibala EC, Li D, Gunewardena S, Jensen RA. BRCA1 regulation of epidermal growth factor receptor (EGFR) expression in human breast cancer cells involves microRNA-146a and is critical for its tumor suppressor function. Oncogene. 34: 4333-46. PMID 25417703 DOI: 10.1038/Onc.2014.363  0.52
2014 Kaushik G, Venugopal A, Ramamoorthy P, Standing D, Subramaniam D, Umar S, Jensen RA, Anant S, Mammen JM. Honokiol inhibits melanoma stem cells by targeting notch signaling. Molecular Carcinogenesis. PMID 25491779 DOI: 10.1002/Mc.22242  0.52
2014 Kaushik G, Kwatra D, Subramaniam D, Jensen RA, Anant S, Mammen JM. Honokiol affects melanoma cell growth by targeting the AMP-activated protein kinase signaling pathway. American Journal of Surgery. 208: 995-1002; discussion. PMID 25450590 DOI: 10.1016/J.Amjsurg.2014.09.014  0.52
2014 Sharma P, Stecklein SR, Kimler BF, Sethi G, Petroff BK, Phillips TA, Tawfik OW, Godwin AK, Jensen RA. The prognostic value of BRCA1 promoter methylation in early stage triple negative breast cancer. Journal of Cancer Therapeutics & Research. 3: 1-11. PMID 25177489 DOI: 10.7243/2049-7962-3-2  0.56
2014 Sharma P, Klemp JR, Kimler BF, Mahnken JD, Geier LJ, Khan QJ, Elia M, Connor CS, McGinness MK, Mammen JM, Wagner JL, Ward C, Ranallo L, Knight CJ, Stecklein SR, ... Jensen RA, et al. Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing. Breast Cancer Research and Treatment. 145: 707-14. PMID 24807107 DOI: 10.1007/S10549-014-2980-0  0.52
2014 Paul A, Gunewardena S, Stecklein SR, Saha B, Parelkar N, Danley M, Rajendran G, Home P, Ray S, Jokar I, Vielhauer GA, Jensen RA, Tawfik O, Paul S. PKCλ/ι signaling promotes triple-negative breast cancer growth and metastasis. Cell Death and Differentiation. 21: 1469-81. PMID 24786829 DOI: 10.1038/Cdd.2014.62  0.52
2014 Neradugomma NK, Subramaniam D, Tawfik OW, Goffin V, Kumar TR, Jensen RA, Anant S. Prolactin signaling enhances colon cancer stemness by modulating Notch signaling in a Jak2-STAT3/ERK manner. Carcinogenesis. 35: 795-806. PMID 24265293 DOI: 10.1093/Carcin/Bgt379  0.52
2014 Stecklein SR, Jensen RA. Breast cancer stem cells Stem Cells and Human Diseases. 451-465. DOI: 10.1007/978-94-007-2801-1_20  0.52
2013 Li D, Kumaraswamy E, Harlan-Williams LM, Jensen RA. The role of BRCA1 and BRCA2 in prostate cancer. Frontiers in Bioscience (Landmark Edition). 18: 1445-59. PMID 23747895 DOI: 10.2741/4191  0.52
2013 Ahmed I, Roy B, Chandrakesan P, Venugopal A, Xia L, Jensen R, Anant S, Umar S. Evidence of functional cross talk between the Notch and NF-κB pathways in nonneoplastic hyperproliferating colonic epithelium. American Journal of Physiology. Gastrointestinal and Liver Physiology. 304: G356-70. PMID 23203159 DOI: 10.1152/Ajpgi.00372.2012  0.52
2012 Stecklein SR, Kumaraswamy E, Behbod F, Wang W, Chaguturu V, Harlan-Williams LM, Jensen RA. BRCA1 and HSP90 cooperate in homologous and non-homologous DNA double-strand-break repair and G2/M checkpoint activation. Proceedings of the National Academy of Sciences of the United States of America. 109: 13650-5. PMID 22869732 DOI: 10.1073/Pnas.1203326109  0.52
2012 Stecklein SR, Jensen RA. Identifying and exploiting defects in the Fanconi anemia/BRCA pathway in oncology. Translational Research : the Journal of Laboratory and Clinical Medicine. 160: 178-97. PMID 22683426 DOI: 10.1016/J.Trsl.2012.01.022  0.52
2012 Stecklein SR, Jensen RA, Pal A. Genetic and epigenetic signatures of breast cancer subtypes. Frontiers in Bioscience (Elite Edition). 4: 934-49. PMID 22201926  0.52
2011 Sharma P, Kimler BF, Park YA, Stecklein SR, Khan QJ, Petroff BK, Tawfik OW, Jensen RA. Association of BRCA1 promoter methylation in triple-negative breast cancer (TNBC) with resistance to standard anthracyline-based adjuvant chemotherapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 1123. PMID 28021523 DOI: 10.1200/Jco.2011.29.15_Suppl.1123  0.56
2011 Subramaniam D, Nicholes ND, Dhar A, Umar S, Awasthi V, Welch DR, Jensen RA, Anant S. 3,5-bis(2,4-difluorobenzylidene)-4-piperidone, a novel compound that affects pancreatic cancer growth and angiogenesis. Molecular Cancer Therapeutics. 10: 2146-56. PMID 21890747 DOI: 10.1158/1535-7163.Mct-11-0399  0.52
2011 Subramaniam D, Ramalingam S, Linehan DC, Dieckgraefe BK, Postier RG, Houchen CW, Jensen RA, Anant S. RNA binding protein CUGBP2/CELF2 mediates curcumin-induced mitotic catastrophe of pancreatic cancer cells. Plos One. 6: e16958. PMID 21347286 DOI: 10.1371/Journal.Pone.0016958  0.52
2011 Kumaraswamy E, Stecklein SR, Augustine LA, Jensen RA. Abstract 1188: BRCA1 regulates EGFR expression through microRNAs Cancer Research. 71: 1188-1188. DOI: 10.1158/1538-7445.Am2011-1188  0.56
2011 Jensen RA, Harlan-Williams LM, Wang W, Stecklein SR. Basic cancer biology and immunology Principles and Practice of Fertility Preservation. 35-48. DOI: 10.1017/CBO9780511921896.007  0.52
2010 Harlan-Williams LM, Overton JA, Stecklein SR, Wang W, Jensen RA. Abstract 757: Identification and characterization of small molecule activators of BRCA1 expression Cancer Research. 70: 757-757. DOI: 10.1158/1538-7445.Am10-757  0.56
2010 Wang W, Harlan-Williams LM, Jensen RA. Abstract 494: Identification and characterization of novel kinases that regulate BRCA1 expression and function Cancer Research. 70: 494-494. DOI: 10.1158/1538-7445.Am10-494  0.36
2010 Stecklein SR, Harlan-Williams LM, Wang W, Eskew JD, Chaguturu V, Jensen RA. Abstract 1391: Inhibition of Hsp90 induces BRCA1 degradation and hypersensitivity to ionizing radiation Cancer Research. 70: 1391-1391. DOI: 10.1158/1538-7445.Am10-1391  0.56
2008 Rizki A, Weaver VM, Lee SY, Rozenberg GI, Chin K, Myers CA, Bascom JL, Mott JD, Semeiks JR, Grate LR, Mian IS, Borowsky AD, Jensen RA, Idowu MO, Chen F, et al. A human breast cell model of preinvasive to invasive transition. Cancer Research. 68: 1378-87. PMID 18316601 DOI: 10.1158/0008-5472.Can-07-2225  0.52
2007 Hoshino A, Yee CJ, Campbell M, Woltjer RL, Townsend RL, van der Meer R, Shyr Y, Holt JT, Moses HL, Jensen RA. Effects of BRCA1 transgene expression on murine mammary gland development and mutagen-induced mammary neoplasia. International Journal of Biological Sciences. 3: 281-91. PMID 17505536 DOI: 10.7150/Ijbs.3.281  0.52
2006 McLaren BK, Schuyler PA, Sanders ME, Jensen RA, Simpson JF, Dupont WD, Page DL. Excellent survival, cancer type, and Nottingham grade after atypical lobular hyperplasia on initial breast biopsy. Cancer. 107: 1227-33. PMID 16894523 DOI: 10.1002/cncr.22113  0.52
2004 Kasami M, Jensen RA, Simpson JF, Page DL. Lobulocentricity of breast hypersecretory hyperplasia with cytologic atypia: infrequent association with carcinoma in situ. American Journal of Clinical Pathology. 122: 714-20. PMID 15491967 DOI: 10.1309/P90D-5BWT-RA65-P1LW  0.52
2004 Chaurand P, Sanders ME, Jensen RA, Caprioli RM. Proteomics in diagnostic pathology: profiling and imaging proteins directly in tissue sections. The American Journal of Pathology. 165: 1057-68. PMID 15466373 DOI: 10.1016/S0002-9440(10)63367-6  0.52
2003 Gorska AE, Jensen RA, Shyr Y, Aakre ME, Bhowmick NA, Moses HL. Transgenic mice expressing a dominant-negative mutant type II transforming growth factor-beta receptor exhibit impaired mammary development and enhanced mammary tumor formation. The American Journal of Pathology. 163: 1539-49. PMID 14507660 DOI: 10.1016/S0002-9440(10)63510-9  0.52
2003 Gobbi H, Simpson JF, Jensen RA, Olson SJ, Page DL. Metaplastic spindle cell breast tumors arising within papillomas, complex sclerosing lesions, and nipple adenomas. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 16: 893-901. PMID 13679453 DOI: 10.1097/01.MP.0000085027.75201.B5  0.52
2003 Campbell M, Qu S, Wells S, Sugandha H, Jensen RA. An adenoviral vector containing an arg-gly-asp (RGD) motif in the fiber knob enhances protein product levels from transgenes refractory to expression. Cancer Gene Therapy. 10: 559-70. PMID 12833136 DOI: 10.1038/sj.cgt.7700599  0.52
2003 Jensen RA, Page DL. Ductal carcinoma in situ of the breast: impact of pathology on therapeutic decisions. The American Journal of Surgical Pathology. 27: 828-31. PMID 12766588 DOI: 10.1097/00000478-200306000-00015  0.52
2003 Page DL, Schuyler PA, Dupont WD, Jensen RA, Plummer WD, Simpson JF. Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet (London, England). 361: 125-9. PMID 12531579 DOI: 10.1016/S0140-6736(03)12230-1  0.52
2002 Xu BJ, Caprioli RM, Sanders ME, Jensen RA. Direct analysis of laser capture microdissected cells by MALDI mass spectrometry. Journal of the American Society For Mass Spectrometry. 13: 1292-7. PMID 12443019 DOI: 10.1016/S1044-0305(02)00644-X  0.52
2001 Ely KA, Carter BA, Jensen RA, Simpson JF, Page DL. Core biopsy of the breast with atypical ductal hyperplasia: a probabilistic approach to reporting. The American Journal of Surgical Pathology. 25: 1017-21. PMID 11474285 DOI: 10.1097/00000478-200108000-00005  0.52
2001 Carter BA, Page DL, Schuyler P, Parl FF, Simpson JF, Jensen RA, Dupont WD. No elevation in long-term breast carcinoma risk for women with fibroadenomas that contain atypical hyperplasia. Cancer. 92: 30-6. PMID 11443606 DOI: 10.1002/1097-0142(20010701)92:1<30::Aid-Cncr1288>3.0.Co;2-2  0.52
2001 Campbell M, Aprelikova ON, van der Meer R, Woltjer RL, Yee CJ, Liu ET, Jensen RA. Construction and characterization of recombinant adenoviruses expressing human BRCA1 or murine Brca1 genes. Cancer Gene Therapy. 8: 231-9. PMID 11332994 DOI: 10.1038/Sj.Cgt.7700291  0.52
2000 Cardiff RD, Moghanaki D, Jensen RA. Genetically engineered mouse models of mammary intraepithelial neoplasia. Journal of Mammary Gland Biology and Neoplasia. 5: 421-37. PMID 14973386 DOI: 10.1023/A:1009534129331  0.52
2000 Cardiff RD, Anver MR, Gusterson BA, Hennighausen L, Jensen RA, Merino MJ, Rehm S, Russo J, Tavassoli FA, Wakefield LM, Ward JM, Green JE. The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting. Oncogene. 19: 968-88. PMID 10713680  0.52
2000 Carter BA, Jensen RA, Simpson JF, Page DL. Benign transport of breast epithelium into axillary lymph nodes after biopsy. American Journal of Clinical Pathology. 113: 259-65. PMID 10664628 DOI: 10.1309/7EF8-F1W7-YVNT-H8H5  0.52
1999 Aprelikova ON, Fang BS, Meissner EG, Cotter S, Campbell M, Kuthiala A, Bessho M, Jensen RA, Liu ET. BRCA1-associated growth arrest is RB-dependent. Proceedings of the National Academy of Sciences of the United States of America. 96: 11866-71. PMID 10518542 DOI: 10.1073/Pnas.96.21.11866  0.52
1999 Gobbi H, Simpson JE, Jensen RA, Coogan AC, Page DL, Pacelli A, Bostwick DG. Prostatic adenocarcinoma with glomeruloid features [3] (multiple letters) Human Pathology. 30: 111-112. PMID 9923939 DOI: 10.1016/S0046-8177(99)90314-3  0.52
1996 Page DL, Jensen RA. Ductal carcinoma in situ of the breast: Understanding the misunderstood stepchild Journal of the American Medical Association. 275: 948-949. PMID 8598624 DOI: 10.1001/Jama.1996.03530360058039  0.52
1995 Page DL, Jensen RA. Angiogenesis in human breast carcinoma: What is the question? Human Pathology. 26: 1173-1174. PMID 7590687 DOI: 10.1016/0046-8177(95)90188-4  0.52
1994 Page DL, Jensen RA. Evaluation and management of high risk and premalignant lesions of the breast World Journal of Surgery. 18: 32-38. PMID 8197774 DOI: 10.1007/BF00348189  0.52
1993 Jensen RA, Page DL. p53: The promising story continues to unfold Human Pathology. 24: 455-456. PMID 8491487 DOI: 10.1016/0046-8177(93)90155-A  0.52
1988 Jensen RA, Page DL. Cystic hypersecretory carcinoma: what's in a name? Archives of Pathology and Laboratory Medicine. 112: 1179. PMID 2847682  0.52
1986 Van Eldik LJ, Jensen RA, Ehrenfried BA, Whetsell WO. Immunohistochemical localization of S100 beta in human nervous system tumors by using monoclonal antibodies with specificity for the S100 beta polypeptide. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 34: 977-82. PMID 3734419 DOI: 10.1177/34.8.3734419  0.52
1984 Van Eldik LJ, Ehrenfried B, Jensen RA. Production and characterization of monoclonal antibodies with specificity for the S100 beta polypeptide of brain S100 fractions. Proceedings of the National Academy of Sciences of the United States of America. 81: 6034-8. PMID 6207537  0.52
Show low-probability matches.